Business
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...
Hi, what are you looking for?
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...
– It was a well-publicized food scandal. Unilever, owner of Hellman’s Real Mayonnaise had a bone to pick with Hampton Creek over its...
The mayonnaise war rages on. Unilever is suing Hampton Creek for false advertising. Unilever claims that a cracked egg on the packaging of Hampton...
A spray Ebola vaccine protects monkeys from the virus 100 percent of the time, and the protection lasts as long as a year, researchers...
– Intec Pharma says it expects the Phase III trial for its Accordion Pill Levodopa to take place in the second half of 2015....
Israel’s Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has received a...
– A disappointment to the company : raised less than planned, but saw its share price double on its first day’s trading . – Israeli Exoskeleton...
– Teva is battling generic versions of the 20 mg and 40 mg dosages of its MS blockbuster. – In the absence of...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has recalled a batch of its generic Parkinson’s combination drug treatment carbidopa/levodopa because of concern that...
– The company plans the offering in the second week of September. – – ReWalk Robotics has set terms for its Nasdaq IPO. The...